EGFR and gastric cancer: In the treatment of MDR gastric cancer cells, we speculate that miR-1323 may be a functional target of elemene to reverse drug resistance, and elemene inhibited miR-1323, which in turn upregulated Cbl-b expression and then inhibited the EGFR-ERK/Akt pathway.